MLH1 and cancer: Of note, zonal heterogeneity of the staining with areas of the tumor showing an abrupt loss of MLH1 and PMS2 protein expression may be an indicator of acquired inactivating alterations of MLH1 (primarily, MLH1 promoter hypermethylation), arguing for sporadic cancer rather than LS-related cancer [250,251].